Erech Finance Cahalacha Ltd - Asset Resilience Ratio
Erech Finance Cahalacha Ltd (EFNC) has an Asset Resilience Ratio of 5.62% as of December 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Erech Finance Cahalacha Ltd short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2018–2023)
This chart shows how Erech Finance Cahalacha Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see balance sheet size of Erech Finance Cahalacha Ltd.
Liquid Assets Composition Over Time
This chart breaks down Erech Finance Cahalacha Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read EFNC liabilities breakdown for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ILA0.00 | 0% |
| Short-term Investments | ILA1.32 Million | 5.62% |
| Total Liquid Assets | ILA1.32 Million | 5.62% |
Asset Resilience Insights
- Limited Liquidity: Erech Finance Cahalacha Ltd maintains only 5.62% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Erech Finance Cahalacha Ltd Industry Peers by Asset Resilience Ratio
Compare Erech Finance Cahalacha Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
TransMedics Group Inc
NASDAQ:TMDX |
Medical Devices | 0.00% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.84% |
|
Novocure Ltd
NASDAQ:NVCR |
Medical Devices | 43.72% |
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 34.37% |
|
Hangzhou AGS MedTech Co. Ltd. A
SHG:688581 |
Medical Devices | 18.80% |
|
Nanjing Vishee Medical Technology Co Ltd
SHG:688580 |
Medical Devices | 10.74% |
|
Nanjing Medlander Medical Technology Co. Ltd. A
SHG:688273 |
Medical Devices | 34.29% |
Annual Asset Resilience Ratio for Erech Finance Cahalacha Ltd (2018–2023)
The table below shows the annual Asset Resilience Ratio data for Erech Finance Cahalacha Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-12-31 | 5.62% | ILA1.32 Million ≈ $3.54K |
ILA23.47 Million ≈ $62.93K |
+2.70pp |
| 2021-12-31 | 2.92% | ILA3.05 Million ≈ $8.17K |
ILA104.54 Million ≈ $280.26K |
-5.11pp |
| 2020-12-31 | 8.03% | ILA5.88 Million ≈ $15.77K |
ILA73.27 Million ≈ $196.44K |
+7.69pp |
| 2019-12-31 | 0.34% | ILA209.00K ≈ $560.32 |
ILA61.22 Million ≈ $164.12K |
-10.03pp |
| 2018-12-31 | 10.37% | ILA6.11 Million ≈ $16.39K |
ILA58.97 Million ≈ $158.09K |
-- |
About Erech Finance Cahalacha Ltd
Erech Finance Cahalacha Ltd, together with its subsidiaries, provides loans and credit services to small and medium sized enterprises, associations, and private borrowers in Israel. It is also involved in the development of biomed-drugs in the areas of juvenile diabetes and cancer. The company was founded in 1998 and is based in Jerusalem, Israel.